Detailed price information for Aeon Biopharma Inc (AEON-A) from The Globe and Mail including charting and trades.
AEON Biopharma, Inc. announced plans to advance its biosimilar product ABP-450, leveraging the 351(k) regulatory pathway with the goal of obtaining FDA approval for all indications currently listed ...
Bencich, 49, previously worked as chief executive of Achieve Life Sciences from September 2020 to August 2024. He was chief operating officer of Achieve for three years before that. Aeon said Monday ...
Announced positive initial comparative analytical results, confirming identical amino-acid sequencing and highly similar functional characteristics to BOTOX® – – Reported positive FDA BPD Type 2a ...
The latest announcement is out from AEON Co ( (JP:8267)). AEON Group companies U.S.M.H, Maxvalu Kanto, Daiei, and AEON MARKET have approved a multi-step business integration designed to strengthen ...
AEON Biopharma, Inc. announced the appointment of Rob Bancroft as President and CEO, alongside the approval of inducement awards by the Compensation Committee of the Board of Directors. Bancroft will ...
HONG KONG, March 12, 2026 /PRNewswire/ -- 2025 is a year where crypto truly went mainstream. Regulatory clarity around ETFs, compliant distribution channels, and the emergence of publicly listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results